Life Scientist > Biotechnology

More light for Clinuvel

23 September, 2008 by Dylan Bushell-Embling

Clinuvel to test CUV1657 as adjunct therapy in cancer patients


Aussie gets WIPO

23 September, 2008 by Kate McDonald

Francis Gurry appointed head of UN IP agency


Day of the iguana

18 September, 2008 by Kate McDonald

ANU researchers have discovered a new species of iguana in Fiji


ComBio: Flii and the elephant in the room

18 September, 2008 by Fiona Wylie

A symposium at ComBio on wound healing promises to take audiences on a journey from basic cell biology right through to 3D skin scaffolds as therapies.


Funds for venture capitalists

18 September, 2008 by Kate McDonald

Three new fund managers selected for Innovation Investment Fund


NuSep licences gels

17 September, 2008 by Dylan Bushell-Embling

NuSep to licence out electrophoresis gels business


ChemGenex raises $12.9m

17 September, 2008 by Dylan Bushell-Embling

Major shareholders chip in half of capital raising


HeartWare vote for US move

17 September, 2008 by Dylan Bushell-Embling

Court approves shareholder vote on HeartWare's plans to redomicile


CathRx sells first product to Europe

17 September, 2008 by Dylan Bushell-Embling

Diagnostic modular heart catheters first of several planned for European market


Vascular patent for HealthLinx

17 September, 2008 by Dylan Bushell-Embling

HealthLinx granted US patent for vascular permeability program


Leggett action continues

16 September, 2008 by Dylan Bushell-Embling

Litigation against former Agenix CEO Neil Leggett to continue next week


Pharmaxis banks

16 September, 2008 by Dylan Bushell-Embling

Pharmaxis in strong cash position for FY09


BioDiem at Portugal flu conference

16 September, 2008 by Dylan Bushell-Embling

BioDiem presents LAIV research at influenza conference


Millipore product guide to antibodies

16 September, 2008 by External Press Release Author

Millipore announces the availability of its new Antibodies and Kits Product Guide, a comprehensive resource for navigating Millipore’s antibodies, immunoassay products and recombinant proteins for over 2500 unique targets.


Vaccines and the world

12 September, 2008 by Staff Writers

The World Vaccines Congress is coming to Sydney next month


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd